BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7890662)

  • 1. Rapid decline in folylpolyglutamate synthetase activity and gene expression during maturation of HL-60 cells. Nature of the effect, impact on folate compound polyglutamate pools, and evidence for programmed down-regulation during maturation.
    Egan MG; Sirlin S; Rumberger BG; Garrow TA; Shane B; Sirotnak FM
    J Biol Chem; 1995 Mar; 270(10):5462-8. PubMed ID: 7890662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription.
    Roy K; Mitsugi K; Sirlin S; Shane B; Sirotnak FM
    J Biol Chem; 1995 Nov; 270(45):26918-22. PubMed ID: 7592937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
    Rots MG; Pieters R; Peters GJ; Noordhuis P; van Zantwijk CH; Kaspers GJ; Hählen K; Creutzig U; Veerman AJ; Jansen G
    Blood; 1999 Mar; 93(5):1677-83. PubMed ID: 10029597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of folate analogue transport inward after induced maturation of HL-60 leukemia cells. Molecular properties of the transporter in an overproducing variant and evidence for down-regulation of its synthesis in maturating cells.
    Yang CH; Pain J; Sirotnak FM
    J Biol Chem; 1992 Apr; 267(10):6628-34. PubMed ID: 1551871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells.
    Johnson TB; Nair MG; Galivan J
    Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of drug-exposure conditions on the development of resistance to methotrexate or ZD1694 in cultured human leukaemia cells.
    Takemura Y; Kobayashi H; Gibson W; Kimbell R; Miyachi H; Jackman AL
    Int J Cancer; 1996 Mar; 66(1):29-36. PubMed ID: 8608962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase.
    McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK
    Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of folylpolyglutamate synthetase and gamma-glutamyl hydrolase in altering cellular folyl- and antifolylpolyglutamates.
    Galivan J; Johnson T; Rhee M; McGuire JJ; Priest D; Kesevan V
    Adv Enzyme Regul; 1987; 26():147-55. PubMed ID: 3499766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
    Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
    Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
    Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
    Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of folate analogue transport following induced maturation of HL-60 leukemia cells. Early decline in mediated influx, relationship to commitment, and functional dissociation of entry and exit routes.
    Sirotnak FM; Jacobsen DM; Yang CH
    J Biol Chem; 1986 Aug; 261(24):11150-5. PubMed ID: 3460993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable expression of the folylpolyglutamate synthetase gene at the level of mRNA transcription in human leukemia cell lines sensitive, or made resistant, to various antifolate drugs.
    Takemura Y; Kobayashi H; Miyachi H
    Anticancer Drugs; 1999 Aug; 10(7):677-83. PubMed ID: 10507318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol-associated folate disturbances result in altered methylation of folate-regulating genes.
    Wani NA; Hamid A; Kaur J
    Mol Cell Biochem; 2012 Apr; 363(1-2):157-66. PubMed ID: 22147198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
    McGuire JJ; Russell CA
    Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth rate and methotrexate on folate polyglutamates and folylpolyglutamate hydrolase activity in Krebs ascites cells.
    Sur P; Priest DG; Doig MT
    Biochem Cell Biol; 1986 Apr; 64(4):363-7. PubMed ID: 3755049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular pharmacokinetic of methotrexate and its modulation by folylpolyglutamate synthetase and γ-glutamyl hydrolase in tumor cells.
    Tang F; Zou L; Chen J; Meng F
    PLoS One; 2024; 19(6):e0302663. PubMed ID: 38833640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate.
    Sohn KJ; Smirnakis F; Moskovitz DN; Novakovic P; Yates Z; Lucock M; Croxford R; Kim YI
    Gut; 2004 Dec; 53(12):1825-31. PubMed ID: 15542523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients.
    Odin E; Wettergren Y; Nilsson S; Willén R; Carlsson G; Spears CP; Larsson L; Gustavsson B
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6012-9. PubMed ID: 14676127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptionally mediated decreases in folylpolyglutamate synthetase gene expression in some folate analogue-resistant variants of the L1210 cell. Evidence for an altered cognate mRNA in the variants affecting the rate of de novo synthesis of the enzyme.
    Roy K; Egan MG; Sirlin S; Sirotnak FM
    J Biol Chem; 1997 Mar; 272(11):6903-8. PubMed ID: 9054377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.